Literature DB >> 24845269

Association of endothelial nitric oxide synthase gene polymorphisms (894G/T, -786T/C, G10T) and clinical findings in patients with migraine.

Recep Eröz1, Anzel Bahadir, Suber Dikici, Sener Tasdemir.   

Abstract

Migraine is a common neurological disorder characterized by recurrent attacks, unilateral head pain, and related symptoms. The aim of this study was to investigate three endothelial nitric oxide synthase (eNOS) polymorphisms in 176 patients with migraine and 123 healthy individuals. Clinical and biochemical parameters were investigated. Genetic analysis was performed using the polymerase chain reaction-restriction fragment length polymorphism method. The differences between migraine cases and the control group were significant for two polymorphisms (-786T/C and 894G/T) (p = 0.000). Homocysteine and body mass index (BMI) were significantly higher in the migraine group than in the control group (p = 0.001 and p = 0.000). The relation between -786T/C genotype and BMI and allodynia was significant. TC heterozygotes and CC homozygotes were significantly higher in the migraine group than in the control group (OR 2.843 and 95 % CI 1.681-4.808 and OR 3.729 and 95 % CI 1.784-7.792, respectively). The 894G/T genotype was correlated with BMI, pain intensity, age at the onset of migraine, nausea, tension, compression, and allodynia. For this polymorphism, GT heterozygotes and TT homozygotes were significantly higher in the migraine group than in the control group (OR 3.027 and 95 % CI 1.830-5.008 and OR 3.221 and 95 % CI 1.223-8.484, respectively). The G10T genotype was correlated with attack duration and age at the onset of migraine (p = 0.008 and p = 0.040). eNOS polymorphisms may be useful markers for assessing migraine risk and clinical diagnosis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24845269     DOI: 10.1007/s12017-014-8311-0

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  45 in total

1.  Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene.

Authors:  P A Marsden; H H Heng; S W Scherer; R J Stewart; A V Hall; X M Shi; L C Tsui; K T Schappert
Journal:  J Biol Chem       Date:  1993-08-15       Impact factor: 5.157

2.  Vascular endothelial growth factor genetic polymorphisms and haplotypes in women with migraine.

Authors:  Flavia M Gonçalves; Alisson Martins-Oliveira; Jose G Speciali; Tatiane C Izidoro-Toledo; Marcelo R Luizon; Fabiola Dach; Jose E Tanus-Santos
Journal:  DNA Cell Biol       Date:  2010-07       Impact factor: 3.311

Review 3.  An update on the blood vessel in migraine.

Authors:  K C Brennan; Andrew Charles
Journal:  Curr Opin Neurol       Date:  2010-06       Impact factor: 5.710

Review 4.  Current concepts of the pathophysiology of migraine.

Authors:  P J Goadsby
Journal:  Neurol Clin       Date:  1997-02       Impact factor: 3.806

5.  Endothelial nitric oxide synthase haplotypes associated with aura in patients with migraine.

Authors:  Flavia M Gonçalves; Alisson Martins-Oliveira; Jose G Speciali; Marcelo R Luizon; Tatiane C Izidoro-Toledo; Pamela S Silva; Fabiola Dach; Jose E Tanus-Santos
Journal:  DNA Cell Biol       Date:  2011-02-20       Impact factor: 3.311

6.  Different circulating metalloproteinases profiles in women with migraine with and without aura.

Authors:  Alisson Martins-Oliveira; Jose G Speciali; Fabiola Dach; Andrea M Marcaccini; Flavia M Gonçalves; Raquel F Gerlach; J E Tanus-Santos
Journal:  Clin Chim Acta       Date:  2009-07-20       Impact factor: 3.786

Review 7.  Pharmacogenetics of migraine: genetic variants and their potential role in migraine therapy.

Authors:  F Fernandez; N J Colson; L R Griffiths
Journal:  Pharmacogenomics       Date:  2007-06       Impact factor: 2.533

8.  Endothelial nitric oxide synthase haplotypes associated with hypertension do not predispose to cardiac hypertrophy.

Authors:  Vivian Vasconcellos; Riccardo Lacchini; Anna L B Jacob-Ferreira; Maria L Sales; Maria C Ferreira-Sae; Roberto Schreiber; Wilson Nadruz; Jose E Tanus-Santos
Journal:  DNA Cell Biol       Date:  2010-04       Impact factor: 3.311

9.  Body mass index and headaches: findings from a national sample of US adults.

Authors:  E S Ford; C Li; W S Pearson; G Zhao; T W Strine; A H Mokdad
Journal:  Cephalalgia       Date:  2008-08-22       Impact factor: 6.292

10.  Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2.

Authors:  Maurizio De Fusco; Roberto Marconi; Laura Silvestri; Luigia Atorino; Luca Rampoldi; Letterio Morgante; Andrea Ballabio; Paolo Aridon; Giorgio Casari
Journal:  Nat Genet       Date:  2003-01-21       Impact factor: 38.330

View more
  9 in total

Review 1.  Targeted Nitric Oxide Synthase Inhibitors for Migraine.

Authors:  Amynah A Pradhan; Zachariah Bertels; Simon Akerman
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

2.  Symmetric Dimethylarginine is Altered in Patients After Myocardial Infarction and Predicts Adverse Outcomes.

Authors:  Aleksandra Gąsecka; Piotr Szwed; Karolina Jasińska; Oliwia Fidali; Aleksandra Kłębukowska; Ceren Eyileten; Marek Postula; Łukasz Szarpak; Tomasz Mazurek; Grzegorz Opolski; Krzysztof J Filipiak; Marcin Ufnal
Journal:  J Inflamm Res       Date:  2021-08-10

Review 3.  Glucose-Related Traits and Risk of Migraine-A Potential Mechanism and Treatment Consideration.

Authors:  Md Rafiqul Islam; Dale R Nyholt
Journal:  Genes (Basel)       Date:  2022-04-22       Impact factor: 4.141

4.  Association between endothelial nitric oxide synthase (NOS3) rs2070744 and the risk for migraine.

Authors:  Elena García-Martín; Santiago Navarro-Muñoz; Christopher Rodriguez; Mercedes Serrador; Hortensia Alonso-Navarro; Marisol Calleja; Laura Turpín-Fenoll; Marta Recio-Bermejo; Rafael García-Ruiz; Jorge Millán-Pascual; Francisco Navacerrada; José Francisco Plaza-Nieto; Esteban García-Albea; José A G Agúndez; Félix Javier Jiménez-Jiménez
Journal:  Pharmacogenomics J       Date:  2019-12-03       Impact factor: 3.550

5.  Tumor Necrosis Factor (TNF) -308G>A, Nitric Oxide Synthase 3 (NOS3) +894G>T Polymorphisms and Migraine Risk: A Meta-Analysis.

Authors:  Min Chen; Wenjing Tang; Lei Hou; Ruozhuo Liu; Zhao Dong; Xun Han; Xiaofei Zhang; Dongjun Wan; Shengyuan Yu
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

6.  Role of polymorphisms of inducible nitric oxide synthase and endothelial nitric oxide synthase in idiopathic environmental intolerances.

Authors:  Chiara De Luca; Agnese Gugliandolo; Carlo Calabrò; Monica Currò; Riccardo Ientile; Desanka Raskovic; Ludmila Korkina; Daniela Caccamo
Journal:  Mediators Inflamm       Date:  2015-03-24       Impact factor: 4.711

7.  Endothelial Nitric Oxide Synthase (eNOS) and the Cardiovascular System: in Physiology and in Disease States.

Authors:  N Tran; T Garcia; M Aniqa; S Ali; A Ally; S M Nauli
Journal:  Am J Biomed Sci Res       Date:  2022-01-04

8.  Facilitation of Insulin Effects by Ranolazine in Astrocytes in Primary Culture.

Authors:  Adrián Jordá; Martin Aldasoro; Ignacio Campo-Palacio; Jose M Vila; Constanza Aldasoro; Juan Campos-Campos; Carlos Colmena; Sandeep Kumar Singh; Elena Obrdor; Soraya L Valles
Journal:  Int J Mol Sci       Date:  2022-10-09       Impact factor: 6.208

9.  Endothelial nitric oxide synthase (-786T>C) polymorphism and migraine susceptibility: A meta-analysis.

Authors:  Han Dong; Zhi Hao Wang; Bin Dong; Ya Nan Hu; Hui Ying Zhao
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.